Register
Login:
Share:
Email Facebook Twitter

PHARMA: Heat Biologics - a 'potentially transformative' lung cancer treatment, Phase II data Q3 2018 Watch here

Looking for big risk, big reward investing? See our exclusive Pharma video series from 'Biotech and Money'


Jardine Lloyd Broker Ratings



Broker Ratings for Jardine Lloyd (JLT)


Share Price: 1,304.00Bid: 1,303.00Ask: 1,304.00Change: -4.00 (-0.31%)Faller - Jardine Lloyd
Spread: 1.00Spread as %: 0.08%Open: 1,312.00High: 1,314.00Low: 1,302.00Yesterday’s Close: 1,308.00


Broker Recommendations for Jardine Lloyd (JLT)
DateBrokerRatingOld TargetNew TargetChange
07-Nov-17JP Morgan CazenoveNeutral1,050.001,240.00Reiteration
01-Aug-17JP Morgan CazenoveNeutral1,030.001,050.00Reiteration
27-Jun-17JP Morgan CazenoveNeutral900.001,000.00Reiteration
13-Jun-17HSBCBuy1,250.001,250.00Reiteration
27-Apr-17Numis SecuritiesHold-1,150.00Downgrade
28-Mar-17HSBCBuy1,105.001,250.00Reiteration
01-Mar-17Canaccord GenuityBuy1,070.001,120.00Reiteration
01-Mar-17JP Morgan CazenoveNeutral850.00900.00Reiteration
07-Dec-16RBC Capital MarketsOutperform-1,150.00Reiteration
25-Nov-16HSBCBuy1,100.001,100.00Reiteration
09-Nov-16Canaccord GenuityBuy1,080.001,070.00Reiteration
08-Nov-16numisAdd-1,050.00Reiteration
09-Aug-16JP Morgan CazenoveNeutral1,020.00850.00Reiteration
27-Jul-16JP Morgan CazenoveNeutral970.001,020.00Reiteration
27-Jul-16Canaccord GenuityBuy960.001,080.00Reiteration


Registered members see more Jardine Lloyd broker ratings!
Sign up here for your free account.




Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk






Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.